I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Dulaglutide Alone and in Combination with Empagliflozin Att..:
Katharina Luise Hupa-Breier
;
Janine Dywicki
;
Björn Hartleben
...
https://www.mdpi.com/2227-9059/9/4/353. , 2021
Link:
https://doi.org/10.3390/biomedicines9040353
RT Journal T1
Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:10ab30e20bf14c3cad4a1213c8ed0316&Exemplar=1&LAN=DE A1 Katharina Luise Hupa-Breier A1 Janine Dywicki A1 Björn Hartleben A1 Freya Wellhöner A1 Benjamin Heidrich A1 Richard Taubert A1 Young-Seon Elisabeth Mederacke A1 Maren Lieber A1 Konstantinos Iordanidis A1 Michael P. Manns A1 Heiner Wedemeyer A1 Matthias Hardtke-Wolenski A1 Elmar Jaeckel PB MDPI AG YR 2021 K1 liver disease K1 non-alcoholic steatohepatitis K1 GLP-1 Agonist K1 SGLT-2 inhibitor K1 type 2 diabetes K1 innate immune system K1 Biology (General) K1 QH301-705.5 JF https://www.mdpi.com/2227-9059/9/4/353 LK http://dx.doi.org/https://doi.org/10.3390/biomedicines9040353 DO https://doi.org/10.3390/biomedicines9040353 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)